Ipamorelin
Reported Onset
2–4 weeks
Primary Use
Selective GH release with a favorable safety profile and minimal side effects.
Dose
200mcg - 300mcg
Frequency
2-3x daily (ideally fasted or pre-sleep)
IGF-1 LR3
Reported Onset
2–4 weeks
Primary Use
Enhanced anabolic effects and muscle growth with extended half-life.
Dose
20mcg - 50mcg
Frequency
Daily or post-workout
Community Verdict
Downstream IGF-1 vs upstream GH stimulation — anabolic comparison. The community generally selects between Ipamorelin and IGF-1 LR3 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for Ipamorelin or IGF-1 LR3 at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified